Digital Patient Decision Aid for Oligometastatic Cancer Patients

Health Experiences Overview

This project aims to design, develop, and evaluate a digital patient decision aid (PDA) to customize the delivery of optimal systemic therapy considering its potential for cure versus palliative care and its impact on the quality of life for oligometastatic (OMD) cancer patients. We will ensure the digital PDA's compliance with the International Patient Decision Aid Standards and assess its effects on diverse populations of OMD cancer patients, including those with prostate, non-small cell lung, and head and neck squamous cell cancer. This initiative is part of the CCCZ flagship project OMDZH.

• Nikola Biller-Andorno, Institute of Biomedical Ethics and History of Medicine, University of Zurich
• Armin Biller, Multi-Dimensional Medical Information (MDMI) Lab, Department of Neuroradiology, University of Heidelberg
• Andrea Ferrario, Institute of Biomedical Ethics and History of Medicine, University of Zurich
• Matthias Guckenberger, Department of Radiation Oncology, University of Zurich, University Hospital Zurich
• Sebastian Christ, Department of Radiation Oncology, University Hospital ZurichUniversity Hospital Zurich

Financed by: Comprehensive Cancer Center Zurich

Duration: 2024 – 2026

Detailed description